nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Valganciclovir—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Valganciclovir—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Valganciclovir—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Valganciclovir—Pain—Cisplatin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Valganciclovir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Valganciclovir—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Valganciclovir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Valganciclovir—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Valganciclovir—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Valganciclovir—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Valganciclovir—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Valganciclovir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Valganciclovir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Valganciclovir—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Valganciclovir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Valganciclovir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000457	0.000457	CcSEcCtD
Valganciclovir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Valganciclovir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Valganciclovir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Valganciclovir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Valganciclovir—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Valganciclovir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Valganciclovir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Valganciclovir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Valganciclovir—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Valganciclovir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Valganciclovir—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Valganciclovir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Valganciclovir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Valganciclovir—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Valganciclovir—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Valganciclovir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Valganciclovir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Valganciclovir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Valganciclovir—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Valganciclovir—Constipation—Etoposide—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Valganciclovir—Pain—Etoposide—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Valganciclovir—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Valganciclovir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Valganciclovir—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Valganciclovir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Valganciclovir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Valganciclovir—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Valganciclovir—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Valganciclovir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Valganciclovir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Valganciclovir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Valganciclovir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Valganciclovir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Valganciclovir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Valganciclovir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Valganciclovir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Valganciclovir—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Valganciclovir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Valganciclovir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Valganciclovir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00041	CcSEcCtD
Valganciclovir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Valganciclovir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000406	CcSEcCtD
Valganciclovir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Valganciclovir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Valganciclovir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Valganciclovir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Valganciclovir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Valganciclovir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Valganciclovir—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Valganciclovir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Valganciclovir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Valganciclovir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Valganciclovir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Valganciclovir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Valganciclovir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Valganciclovir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Valganciclovir—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Valganciclovir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Valganciclovir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Valganciclovir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Valganciclovir—Headache—Vincristine—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Valganciclovir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Valganciclovir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Valganciclovir—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000387	CcSEcCtD
Valganciclovir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Valganciclovir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Valganciclovir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Valganciclovir—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Valganciclovir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Valganciclovir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Valganciclovir—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Valganciclovir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Valganciclovir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Valganciclovir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Valganciclovir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Valganciclovir—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Valganciclovir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Valganciclovir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Valganciclovir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Valganciclovir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Valganciclovir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Valganciclovir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
Valganciclovir—Chills—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Valganciclovir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Valganciclovir—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Valganciclovir—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Valganciclovir—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000355	CcSEcCtD
Valganciclovir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000354	0.000354	CcSEcCtD
Valganciclovir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Valganciclovir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Valganciclovir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Valganciclovir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000349	0.000349	CcSEcCtD
Valganciclovir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Valganciclovir—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Valganciclovir—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Valganciclovir—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Valganciclovir—Tension—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Valganciclovir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Valganciclovir—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Valganciclovir—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Valganciclovir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Valganciclovir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Valganciclovir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Valganciclovir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Valganciclovir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Valganciclovir—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Valganciclovir—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Valganciclovir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Valganciclovir—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Valganciclovir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000329	CcSEcCtD
Valganciclovir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Valganciclovir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Valganciclovir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Valganciclovir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Valganciclovir—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Valganciclovir—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Valganciclovir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Valganciclovir—Headache—Etoposide—peripheral nervous system neoplasm	0.000319	0.000319	CcSEcCtD
Valganciclovir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000319	CcSEcCtD
Valganciclovir—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Valganciclovir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000317	CcSEcCtD
Valganciclovir—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Valganciclovir—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000314	CcSEcCtD
Valganciclovir—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000314	CcSEcCtD
Valganciclovir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Valganciclovir—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Valganciclovir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Valganciclovir—Cough—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Valganciclovir—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Valganciclovir—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Valganciclovir—Nausea—Etoposide—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Valganciclovir—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Valganciclovir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Valganciclovir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Valganciclovir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Valganciclovir—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Valganciclovir—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Valganciclovir—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Valganciclovir—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Valganciclovir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Valganciclovir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Valganciclovir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Valganciclovir—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Valganciclovir—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Valganciclovir—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Valganciclovir—Infection—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Valganciclovir—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000282	CcSEcCtD
Valganciclovir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Valganciclovir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Valganciclovir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Valganciclovir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000279	CcSEcCtD
Valganciclovir—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000279	CcSEcCtD
Valganciclovir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Valganciclovir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Valganciclovir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Valganciclovir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Valganciclovir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Valganciclovir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Valganciclovir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Valganciclovir—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Valganciclovir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Valganciclovir—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Valganciclovir—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Valganciclovir—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Valganciclovir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Valganciclovir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Valganciclovir—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Valganciclovir—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Valganciclovir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Valganciclovir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Valganciclovir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Valganciclovir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Valganciclovir—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000254	CcSEcCtD
Valganciclovir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Valganciclovir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Valganciclovir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Valganciclovir—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Valganciclovir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Valganciclovir—Pain—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Valganciclovir—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Valganciclovir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Valganciclovir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000237	CcSEcCtD
Valganciclovir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000236	CcSEcCtD
Valganciclovir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Valganciclovir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Valganciclovir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Valganciclovir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00023	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000228	CcSEcCtD
Valganciclovir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000228	CcSEcCtD
Valganciclovir—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Valganciclovir—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Valganciclovir—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Valganciclovir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Valganciclovir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Valganciclovir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Valganciclovir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00021	CcSEcCtD
Valganciclovir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00021	CcSEcCtD
Valganciclovir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Valganciclovir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Valganciclovir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000205	CcSEcCtD
Valganciclovir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Valganciclovir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Valganciclovir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Valganciclovir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00019	CcSEcCtD
Valganciclovir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Valganciclovir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Valganciclovir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000182	CcSEcCtD
Valganciclovir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000181	CcSEcCtD
Valganciclovir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00018	CcSEcCtD
Valganciclovir—Headache—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000179	CcSEcCtD
Valganciclovir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Valganciclovir—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00017	CcSEcCtD
Valganciclovir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000168	CcSEcCtD
Valganciclovir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
Valganciclovir—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
Valganciclovir—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000157	CcSEcCtD
